Control Bionics (ASX:CBL) raised around AU$2 million via a private placement to two existing shareholders, Nightingale Partners and Phoenix Development Fund, at an issue price of AU$0.045 per share, according to a Tuesday Australian bourse filing.
A total of 4.8 million shares were issued under the firm's share issue capacity.
It will use the proceeds to focus on revenue growth in its core operations and the expansion into new high-potential markets, including the NeuroNode Only and NeuroStrip platforms.
The firm's shares rose 4% on market close Tuesday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。